12886 related articles for article (PubMed ID: 11006577)
1. Antitumor activity of alpha fetoprotein and epidermal growth factor conjugates in vitro and in vivo.
Lutsenko SV; Feldman NB; Finakova GV; Gukasova NV; Petukhov SP; Posypanova GA; Skryabin KG; Severin SE
Tumour Biol; 2000; 21(6):367-74. PubMed ID: 11006577
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic and antitumor activities of doxorubicin conjugates with the epidermal growth factor and its receptor-binding fragment.
Lutsenko SV; Feldman NB; Severin SE
J Drug Target; 2002 Nov; 10(7):567-71. PubMed ID: 12683724
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of alpha-fetoprotein conjugate with doxorubicin in vitro and in vivo.
Feldman NB; Kiselev SM; Gukasova NV; Posypanova GA; Lutsenko SV; Severin SE
Biochemistry (Mosc); 2000 Aug; 65(8):967-71. PubMed ID: 11002192
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic action of conjugates of alpha-fetoprotein and epidermal growth factor with photoheme, chlorines, and phthalocyanines.
Savitsky AA; Gukasova NV; Gumanov SG; Feldman NB; Luk'yanets EA; Mironov AF; Yakubovskaya RI; Lutsenko SV; Severin SE
Biochemistry (Mosc); 2000 Jun; 65(6):732-6. PubMed ID: 10887296
[TBL] [Abstract][Full Text] [Related]
5. Targeting phthalocyanines to tumor cells using epidermal growth factor conjugates.
Lutsenko SV; Feldman NB; Finakova GV; Posypanova GA; Severin SE; Skryabin KG; Kirpichnikov MP; Lukyanets EA; Vorozhtsov GN
Tumour Biol; 1999; 20(4):218-24. PubMed ID: 10393532
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
Burres NS; Clement JJ
Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
Zou Y; Ling YH; Van NT; Priebe W; Perez-Soler R
Cancer Res; 1994 Mar; 54(6):1479-84. PubMed ID: 8137251
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activity, accumulation, and intracellular distribution of anthracycline antibiotics and their conjugates with the epidermal growth factor in sensitive and resistant MCF-7 cells.
Lutsenko SV; Feldman NB; Gumanov SG; Rodina AV; Severin SE
Biochemistry (Mosc); 2000 Nov; 65(11):1299-304. PubMed ID: 11112847
[TBL] [Abstract][Full Text] [Related]
9. [The targetted delivery of antitumor preparations by using protein vectors].
Severin SE; Muĭzhenek EL; Severin ES
Vestn Ross Akad Med Nauk; 1999; (5):22-8. PubMed ID: 10394296
[TBL] [Abstract][Full Text] [Related]
10. A new antitumor agent: methyl sulfonium perchlorate of echinomycin.
Park YS; Kim YH; Kim SK; Choi SJ
Bioorg Med Chem Lett; 1998 Apr; 8(7):731-4. PubMed ID: 9871531
[TBL] [Abstract][Full Text] [Related]
11. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
Watanabe M; Komeshima N; Nakajima S; Tsuruo T
Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
[TBL] [Abstract][Full Text] [Related]
12. Effect of cepharanthine on doxorubicin cytotoxicity in P388 murine leukemia cells in vitro and in vivo.
Fujimura T; Furusawa S; Kawauchi H; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):235-8. PubMed ID: 2047569
[TBL] [Abstract][Full Text] [Related]
13. TMC-69, a new antitumor antibiotic with Cdc25A inhibitory activity, produced by Chrysosporium sp. TC1068. Taxonomy, fermentation and biological activities.
Hirano N; Kohno J; Tsunoda S; Nishio M; Kishi N; Okuda T; Kawano K; Komatsubara S; Nakanishi N
J Antibiot (Tokyo); 2001 May; 54(5):421-7. PubMed ID: 11480885
[TBL] [Abstract][Full Text] [Related]
14. A novel synthetic DNA minor groove binder, MS-247: antitumor activity and cytotoxic mechanism.
Matsuba Y; Edatsugi H; Mita I; Matsunaga A; Nakanishi O
Cancer Chemother Pharmacol; 2000; 46(1):1-9. PubMed ID: 10912571
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
Li LH; Wallace TL; Richard KA; Tracey DE
Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
[TBL] [Abstract][Full Text] [Related]
16. Carcinogenesis and aging. VIII. Effect of host age on tumour growth, metastatic potential, and chemotherapeutic sensitivity to 1.4-benzoquinone-guanylhydrazonethiosemicarbazone (ambazone) and 5-fluorouracil in mice and rats.
Baumgart J; Zhukovskaya NV; Anisimov VN
Exp Pathol; 1988; 33(4):239-48. PubMed ID: 3229459
[TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein-mediated targeting of anti-cancer drugs to tumor cells in vitro.
Severin SE; Moskaleva EYu ; Shmyrev II; Posypanova GA; Belousova YuV ; Sologub VK; Luzhkov YuM ; Nakachian R; Andreani J; Severin ES
Biochem Mol Biol Int; 1995 Oct; 37(2):385-92. PubMed ID: 8673023
[TBL] [Abstract][Full Text] [Related]
18. [Cytological characteristics of carminomycin-resistant P-388 lymphoid leukosis].
Kozinets GI; Ivanova E; Kuznetsova TV; Khanykova OK; Levina NV
Eksp Onkol; 1985; 7(4):60-4, 76. PubMed ID: 4042959
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo anti-tumor activity of L-glutamic acid gamma-monohydroxamate against L1210 leukemia and B16 melanoma.
Vila J; Thomasset N; Navarro C; Doré JF
Int J Cancer; 1990 Apr; 45(4):737-43. PubMed ID: 2323850
[TBL] [Abstract][Full Text] [Related]
20. 13-Deoxycarminomycin, a new biosynthetic anthracycline.
Cassinelli G; Forenza S; Rivola G; Arcamone F; Grein A; Merli S; Casazza AM
J Nat Prod; 1985; 48(3):435-9. PubMed ID: 3861771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
